China Reinsurance (Group) Corporation (HKG:1508)

Market Cap	56.50B
Revenue (ttm)	110.31B
Net Income (ttm)	11.23B
Shares Out	42.48B
EPS (ttm)	0.26
PE Ratio	5.03
Forward PE	7.04
Dividend	0.05 (3.98%)
Ex-Dividend Date	Jul 2, 2025

Volume	32,702,000
Average Volume	34,674,524
Open	1.360
Previous Close	1.370
Day's Range	1.330 - 1.390
52-Week Range	0.520 - 1.470
Beta	0.81
RSI	52.27
Earnings Date	Aug 29, 2025

About Revance Therapeutics

China Reinsurance (Group) Corporation, together with its subsidiaries, operates as a reinsurance company in the People's Republic of China and internationally. The company operates through Property and Casualty Reinsurance, Life and Health Reinsurance, Primary Property and Casualty Insurance, Asset Management, and Other segments. It offers reinsurance products, including motor, commercial and household property, engineering, marine hull and cargo, liability, credit and guarantee, personal accident, health, agriculture, space and aviation, energ...

• Industry: Insurance - Reinsurance
• Sector: Financials
• Founded: 1949
• Employees: 49,040
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1508

Financial Performance

In 2024, China Reinsurance (Group)'s revenue was 103.66 billion, an increase of 9.17% compared to the previous year's 94.96 billion. Earnings were 10.56 billion, an increase of 86.77%.